Literature DB >> 18290762

The pluripotency rheostat Nanog functions as a dimer.

Nicholas P Mullin1, Adam Yates, Arthur J Rowe, Bianca Nijmeijer, Douglas Colby, Paul N Barlow, Malcolm D Walkinshaw, Ian Chambers.   

Abstract

The defining activity of the homeodomain protein Nanog is the ability to confer cytokine-independent self-renewal upon ES (embryonic stem) cells in which it is overexpressed. However, the biochemical basis by which Nanog achieves this function remains unknown. In the present study, we show that Nanog dimerizes through a functionally critical domain. Co-immunoprecipitation of Nanog molecules tagged with distinct epitopes demonstrates that Nanog self-associates through a region in which every fifth residue is tryptophan. In vitro binding experiments establish that this region participates directly in self-association. Moreover, analytical ultracentrifugation indicates that, in solution, Nanog is in equilibrium between monomeric and dimeric forms with a K(d) of 3 muM. The functional importance of Nanog dimerization is established by ES cell colony-forming assays in which deletion of the tryptophan-repeat region eliminates the capacity of Nanog to direct LIF (leukaemia inhibitory factor)-independent self-renewal.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18290762     DOI: 10.1042/BJ20080134

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  40 in total

1.  Phosphorylation stabilizes Nanog by promoting its interaction with Pin1.

Authors:  Matteo Moretto-Zita; Hua Jin; Zhouxin Shen; Tongbiao Zhao; Steven P Briggs; Yang Xu
Journal:  Proc Natl Acad Sci U S A       Date:  2010-07-09       Impact factor: 11.205

2.  Nanog gene: genomic organization and expression in the vole Microtus rossiaemeridionalis.

Authors:  S P Medvedev; E A Elisaphenko; A I Shevchenko; N A Mazurok; S M Zakian
Journal:  Dokl Biochem Biophys       Date:  2009 Mar-Apr       Impact factor: 0.788

3.  The C-terminal pentapeptide of Nanog tryptophan repeat domain interacts with Nac1 and regulates stem cell proliferation but not pluripotency.

Authors:  Tianhua Ma; Zhe Wang; Yunqian Guo; Duanqing Pei
Journal:  J Biol Chem       Date:  2009-04-14       Impact factor: 5.157

4.  Regulation of the Nanog gene by both positive and negative cis-regulatory elements in embryonal carcinoma cells and embryonic stem cells.

Authors:  Brian Boer; Jesse L Cox; David Claassen; Sunil Kumar Mallanna; Michelle Desler; Angie Rizzino
Journal:  Mol Reprod Dev       Date:  2009-02       Impact factor: 2.609

Review 5.  The transcriptional foundation of pluripotency.

Authors:  Ian Chambers; Simon R Tomlinson
Journal:  Development       Date:  2009-07       Impact factor: 6.868

Review 6.  Concise review: pursuing self-renewal and pluripotency with the stem cell factor Nanog.

Authors:  Arven Saunders; Francesco Faiola; Jianlong Wang
Journal:  Stem Cells       Date:  2013-07       Impact factor: 6.277

Review 7.  Switching on pluripotency: a perspective on the biological requirement of Nanog.

Authors:  Thorold W Theunissen; José C R Silva
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2011-08-12       Impact factor: 6.237

8.  Estrogen-related receptor beta interacts with Oct4 to positively regulate Nanog gene expression.

Authors:  Debbie L C van den Berg; Wensheng Zhang; Adam Yates; Erik Engelen; Katalin Takacs; Karel Bezstarosti; Jeroen Demmers; Ian Chambers; Raymond A Poot
Journal:  Mol Cell Biol       Date:  2008-07-28       Impact factor: 4.272

9.  Nanog variability and pluripotency regulation of embryonic stem cells--insights from a mathematical model analysis.

Authors:  Ingmar Glauche; Maria Herberg; Ingo Roeder
Journal:  PLoS One       Date:  2010-06-21       Impact factor: 3.240

10.  Regulated fluctuations in nanog expression mediate cell fate decisions in embryonic stem cells.

Authors:  Tibor Kalmar; Chea Lim; Penelope Hayward; Silvia Muñoz-Descalzo; Jennifer Nichols; Jordi Garcia-Ojalvo; Alfonso Martinez Arias
Journal:  PLoS Biol       Date:  2009-07-07       Impact factor: 8.029

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.